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ABSTRACT
Multiple regulatory modules contribute to the
complex expression programs realized by many
loci. Although long thought of as isolated compo-
nents, recent studies demonstrate that such regula-
tory sequences can physically associate with
promoters and with each other and may localize to
specific sub-nuclear transcription factories. These
associations provide a substrate for putative inter-
actions and have led to the suggested existence of a
transcriptional interactome. Here, using a controlled
strategy of transgenesis, we analyzed the functional
consequences of regulatory sequence interaction
within the myelin basic protein (mbp) locus.
Interactions were revealed through comparisons of
the qualitative and quantitative expression
programs conferred by an allelic series of 11 differ-
ent enhancer/inter-enhancer combinations ligated
to a common promoter/reporter gene. In a develop-
mentally contextual manner, the regulatory output
of all modules changed markedly in the presence
of other sequences. Predicted by transgene expres-
sion programs, deletion of one such module from
the endogenous locus reduced oligodendrocyte
expression levels but unexpectedly, also attenuated
expression of the overlapping golli transcriptional
unit. These observations support a regulatory
architecture that extends beyond a combinatorial
model to include frequent interactions capable of
significantly modulating the functions conferred
through regulatory modules in isolation.
INTRODUCTION
Gene transcription is controlled at multiple levels with
interactions between cis-acting regulatory modules and
the proximal promoter ﬁguring prominently in the
control of both developmental and lineage restricted
programming. Notable features of many regulatory
modules include clustering of transcription factor-binding
sites (TFBS) (1–3) and inter-species sequence conservation
(4–6). Regulatory function is typically accompanied by a
myriad of local changes including DNA methylation
patterns and the accumulation of speciﬁc histone
isoforms with activity speciﬁc modiﬁcations including
acetylation, methylation and phosphorylation (7,8).
A number of model loci have been investigated in
sufﬁcient depth to expose at least part of the complexity
intrinsic to transcriptional control mechanisms. Notable
among these is the b-globin locus where expanding
models incorporate multiple levels of regulation including
promoter-proximal, enhancer-mediated and domain-wide
components of the transcriptional control mechanism.
These regulatory components include locus control
regions (LCRs) (9,10), insulators and boundary elements
such as CCTC (11,12), DNA methylation; chromatin
modiﬁers and physical interactions mediated among
additional distal regulatory elements [reviewed in (13);
14–16]. Illuminating further levels of regulatory sequence
integration, in sea urchin, the output of transgenes bearing
different regulatory sequence domains revealed an exten-
sive network of functionally signiﬁcant positive and
negative interactions largely accommodated by a logic
circuit model (17–19).
Recent investigations, using chromatin conformation
capture assays and 3D FISH, demonstrate that physical
associations among regulatory sequences are common
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achieving a close proximity of distant regulatory
sequences appears to involve the folding of intervening
chromatin into bundles of loops (22). Similarly, for the
TNF (tumor necrosis factor) locus, intra-chromosomal
looping, inferred from chromatin conformation capture
assays, appears to support simultaneous interactions
among dispersed regulatory modules and the proximal
promoter (15). Predicting their functional signiﬁcance,
associations among regulatory sequences are observed to
change through development in association with evolving
gene expression programs (13,23). Providing a further link
between gene expression and cell type-speciﬁc chromatin
structure, cohesin and mediator localize to and participate
in DNA loop formation at active genes (24). Additionally,
active genes may associate at sub-nuclear transcription
factories (25,26) providing a potential substrate for func-
tionally important cis and trans interactions. This may be
of particular signiﬁcance for co-regulated genes where
their dynamic co-localization at such sites may provide
access to environments enriched in lineage speciﬁc
transcription factors.
Despite the accumulating evidence demonstrating
extensive physical associations and functional integration
among diverse regulatory sequences, isolated regulatory
modules frequently confer expression programs seemingly
accommodated faithfully within the developmental and
lineage-restricted program realized by the endogenous
locus. This is the case for four previously identiﬁed
regulatory modules situated upstream of the myelin
basic protein (mbp) locus, three of which showed autono-
mous targeting to mbp expressing glia (27–31). However,
in earlier investigations we also obtained results suggesting
that interactions with functional consequences occurred
among some of these modules and here we sought to
expose the extent and consequences of interactions
among these four modules in a more comprehensive
manner. We designed reporter constructs such that each
module could be investigated either alone or in partner-
ship with multiple combinations of the other modules. The
in vivo qualitative and quantitative expression programs
conferred at three developmentally signiﬁcant time points
by all constructs were then compared in mice. If a simple
combination of their autonomous outputs were to be
reﬂected in their combined expression programs, function-
ally signiﬁcant interactions would not be indicated.
Conversely, if unique expression programming were
encountered, functionally signiﬁcant interactions would
be implicated.
Mbp is expressed at highest levels in oligodendrocytes in
the central nervous system (CNS) and to lower levels by
Schwann cells in the peripheral nervous system (PNS). In
both cell types, expression begins perinatally, rises to
maximal levels while myelin is elaborated during the
pre-weaning period declining thereafter to reach stable
levels maintained in mature animals (32,33). Four
modules (M1–M4) demonstrating extensive inter-species
conservation are recognized in the ﬁrst 10kb of mouse
mbp 50-ﬂanking sequence (29). M4, the module furthest
upstream at  9.5kb, is a Schwann cell enhancer
(27,29,31). M3, at  5kb, is an oligodendrocyte enhancer
that also demonstrates cryptic, albeit transient, Schwann
cell targeting activity (28). M2, at  700bp has no autono-
mous targeting activity while M1, extending to  377bp,
serves as the proximal promoter and demonstrates au-
tonomous targeting activity in oligodendrocytes (27–30).
To support inter-construct comparisons, constructs were
inserted at a common site in single copy and common
orientation using the HPRT based method of controlled
transgenesis (34). Furthermore, we deleted M3 from the
endogenous mbp locus and compared the expression
program realized in mice by the mutant allele to that of
both the intact mbp locus and relevant reporter genes.
Beyond their previously characterized autonomous
regulatory activities, all mbp modules revealed develop-
mentally contextual interactions that signiﬁcantly altered
their own regulatory capacities and/or those conferred by
other regulatory sequences. These observations lead to a
model in which the autonomous activity revealed by
isolated enhancers is but a limited predictor of their role
within endogenous loci where functionally signiﬁcant
interactions with other regulatory sequences appear to
be common.
MATERIALS AND METHODS
Generation of constructs for HPRT transgenesis
9.5kb is a construct previously described (29) consisting of
9.5kb of the 50-ﬂanking sequence of the mouse mbp gene
fused to the Escherichia coli lacZ gene. The 9.5M3 con-
struct corresponds to 9.5kb with a deletion of a PmlI-
DraI (687bp) fragment containing M3. The 9.5M4 con-
struct corresponds to 9.5kb with a deletion of a SacI-AfeI
(769bp) fragment containing M4. The construct in which
the intervening sequence was deleted (9.5I) was
generated by cutting out a BtrI-PmlI (3.8kb) fragment
from 9.5kb.
Modules with linkers were generated by PCR and
cloned into pENTR1A MCSLacZ a modiﬁcation of
pENTR1A (Invitrogen) containing a multiple cloning
site and a lacZ reporter gene. The primers used to
amplify the modules were the following: (all coordinates
are from the UCSC Mouse browser, July 2007 Assembly).
XM1F: GGACTCGAGGCGTAACTGTGCGTTTTAT
AGGAGA
(chr18:82 723 599–82 723 623)
KM1R: TTTGGTACCCCGGAAGCTGCTGTGGGG
TC
(chr18:82 723 939–82 723 958)
NM2F: AGTGCGGCCGCTGCAGAAAGATGTGGG
AAGTCCT
(chr18:82 723 267–82 723 291)
XM2R: ATACTCGAGGTTTAAAAGGCCACCAGTG
CACA
(chr18:82 723 352–82 723 375)
HM3F: ATAAAGCTTGTGGCAGATTTAGACTCCT
TACCA
(chr18:82 718 977–82 719 000)
NM3R: ATAGCGGCCGCAGCCTGGTTCTGGAGT
TGCG
Nucleic Acids Research,2011, Vol.39, No. 7 2549(chr18:82 719 215–82 719 234)
BM4F: ATAAGATCTTGTGACCCCTTTCTCGAT
GTGG
(chr18:82 714 888–82 714 910)
HM4R: TATAAGCTTAGGCAGCCTAGGCCTGCA
GA
(chr18:82 715 238–82 715 257)
M2(chr18:82 722 949–82 723 392) was cloned into an hsp-
lacZ ‘Entry’ vector (27) based on pENTR1A (Invitrogen,
San Diego, CA, USA) to generate M2hsplacZ. M2 was
ligated upstream of the hsp promoter in reverse orienta-
tion relative to endogenous mbp.
Entry vectors were recombined in vitro with the HPRT
Gateway destination vector using LR clonase
(Invitrogen). Hprt-targeting vectors were sequenced and
40mg was linearized for transfection of embryonic stem
cells.
Generation of targeting vector for M3 deletion in situ
To generate classical and conditional M3 knockout ES
cells, we used a gene targeting vector that contained a
loxP site upstream of M3, a neo cassette for positive
selection ﬂanked by two other loxP sites, and a thymidine
kinase cassette outside of the homology arms for negative
selection (Figure 5). The pPNT vector containing pgk-neo
and thymidine kinase (kindly given by Dr Brigitte
Boldyreff) was modiﬁed by cloning a PCR product of
ﬂoxed M3 (759bp). M3 was ampliﬁed with primers that
contained loxP sites: CACCGCTCGAGCCGCACGTGA
TAACTTCGTATAATGTATGCTATACGAAGTTAT
TTTAAATGGTAAAAACCCC and CGGCACCTGCA
GGGTTTAAACATAACTTCGTATAGCATACATTA
TACGAAGTTATACACGTGGCACTCTGAG. Right
(4.6kb) and left (3.7kb) homology arms were cut from a
vector containing 9.5kb of mbp promoter sequence with
PmlI-KpnI and AfeI-DraI respectively, and then cloned
into pPNT. Upon homologous recombination in ES
cells, clones with ﬂoxed M3 that lost the thymidine
kinase cassette were selected, screened, and used to
generate transgenic mice.
Derivation of transgenic mice
Reporter gene constructs in destination vectors were
transfected into BPES-11 embryonic stem cells generated
in the lab as previously described (35), which bear the hprt
deletion originally described by Hooper et al. (36). Upon
homologous recombination the transgenes insert in single
copy upstream of the hprt gene and only cells with the
insertion are able to grow in hypoxantin–aminopterin–
thymine selection media. Selected and genotyped
embryonic stem cell clones were injected into C57BL/6
blastocysts, which were then transplanted into
pseudo-pregnant females. Male chimeras were mated to
C57BL/6 females for germline passage, which was con-
ﬁrmed by transgene speciﬁc PCR genotyping, and BC2
mice were derived by a subsequent cross between
germ-line females and C57Bl/6 males.
Derivation of M3 knockout mice
The targeting vector was linearized with NotI and trans-
fected by electroporation into BPES-6 mouse embryonic
stem cells (derived together with BPES-11, but without the
hprt deletion). Clones were selected with G418 (200mg/ml)
and ganciclovir (2mM). Clones with the correct recombin-
ation event, as determined by Southern blot hybridization,
were used to obtain germline-transmitting chimeras after
injection of C57BL/6 blastocysts. Chimeras were crossed
with C57BL/6 wild-type mice. Heterozygous offspring
were crossed to Prm-Cre transgenic mice (Jackson
Laboratory), which express Cre recombinase from the
protamine promoter in sperm (37), and further back-
crossed to C57BL/6.
Genotyping of M3KO mice by Southern blot and PCR:
Genomic DNA was extracted from targeted ES cells and
mouse tails. Southern blot hybridization was done with
AseI, EcoRI and SacI-digested genomic DNA using
internal and external probes (Figure 5). Digested gDNA
was transferred to Hybond-N+ membrane (Amersham
Biosciences) and hybridized with probes labeled with
HexaLabel
TM DNA-Labeling Kit (Fermentas). For PCR
genotyping the following primers were used:
M3Hom1F (CAAGGACACATAGAAGATGGGC
TAC) and
M3Hom1R (AGGAAAGGGCAAGACTGAGTGG).
Histochemical detection and quantitation of b-
galactosidase activity
Histochemical staining was performed as described previ-
ously (31). Mice were anesthetized and perfused with 0.5%
paraformaldehyde and 2.5% glutaraldehyde in 0.1M
phosphate buffer pH 7.4. Whole mounts were ﬁxed for
1h and incubated in staining solution with 0.4mg/ml of
Bluo-Gal.
Quantitation of b-galactosidase activity was done in
tissues from mice backcross two to C57BL/6, at P14,
P21 and P90. Mice were anesthetized and tissues
(cervical spinal cords and sciatic nerves) were dissected
and snap-frozen in liquid nitrogen. Four to 10 samples
per construct were homogenized in a mixer mill (Qiagen)
in 1ml (cervical cords) or 0.25ml (sciatic nerves) of lysis
buffer. b-galactosidase activity was detected using the
Galacto-Star
TM System (Applied Biosystems). Total
protein concentrations were measured in triplicate by
Bradford (Bio-Rad) using BSA in a standard curve.
Analysis of variance between groups was performed
using GraphPad Software (GraphPad Software Inc. San
Diego, CA USA) and Statistics tools from Saint John’s
University, Department of physics (www.physics.csbsju
.edu/stats/anova.html). Signiﬁcant differences between
constructs were determined by ANOVA and the criterion
was P<0.01.
Extraction and quantitation of mRNA by real-time PCR
Tissues (cervical spinal cord and optic nerves) from P12,
P21 and P60 anesthetized mice were dissected and
snap-frozen in liquid nitrogen. RNA was prepared from
2550 Nucleic Acids Research, 2011,Vol.39, No. 7single tissues of at least ﬁve mice per genotype with the
Qiagen RNAeasy Lipid mini Kit according to the
protocol. For the optic nerves, RNA was prepared from
pools of ﬁve mice. RNA was reverse transcribed using
Superscript II (Invitrogen) and random hexamers accord-
ing to the protocol of the manufacturer. Quantitative PCR
was performed using the LightCycler FastStart DNA
Master
PLUSSYBR Green I Kit (Roche). The cDNA was
diluted 1/10 and 1/20 and measured using 2ml in a 20-ml
reaction. Golli transcripts were measured using primers
speciﬁc for golli exons 2 and 3 that are present in the
BG21 and J37 isoforms (TTATCTGCTGAGAAGGCC
AGT and CCACGCTTCTCTTCTTTCCA) while mbp
transcripts were measured using primers for mbp exons 3
and 4 (CGAGAACTACCCATTATGGCTCCC and TG
GAGGTGGTGTTCGAGGTGTC) that are present in
the 14-, 17-, 18.5- and 21.5-kDa isoforms as well as the
J37 golli isoform. The much greater abundance of mbp
transcripts in the tissues examined ensures that the mbp
RT–PCR measures mbp transcripts and not the
overlapping golli transcripts. Glyceradehyde-3-phosphate
dehydrogenase (gapdh) cDNA was ampliﬁed with primers:
ACCACAGTCCATGCCATCAC and TCCACCACCCT
GTTGCTGTA. hprt cDNA was ampliﬁed with primers:
GCTGGTGAAAAGGACCTCT and CACAGGACTAG
AACACCTGC. Gapdh and hprt cDNA quantiﬁcation
were used to normalize golli and mbp quantiﬁcation.
RESULTS
Reporter constructs containing most combinations of the
known mbp enhancer and inter-enhancer sequences were
transfected into ES cells where homologous recombin-
ation led to their insertion, in single copy and common
orientation, upstream of HPRT (34). Chimeras were
generated and the single copy transgenes were derived
into lines of mice where their targeting and quantitative
expression phenotypes were evaluated at three develop-
mentally signiﬁcant stages (Figure 1). Throughout the
PNS, Schwann cells initiate myelination perinatally and
by post-natal (P) Day 14, myelin elaboration and myelin
gene expression approach peak levels. Oligodendrocytes
initiate myelinogenesis in different regions of the CNS
during the ﬁrst three post-natal weeks but in the cervical
spinal cord analyzed here, the program is similar to the
PNS, initiating at birth, approaching peak levels by P14
and nearing completion by P21. In mature mice, myelin
protein turnover is thought to be low (38) and myelin gene
expression continues at stable, but reduced from peak,
levels (39–41). To evaluate relative levels of reporter
gene expression in the context of myelin maturation,
b-galactosidase accumulation was measured in cervical
spinal cord (CNS) and sciatic nerve (PNS) samples
obtained at P14, P21 and P90.
Murine mbp 50-ﬂanking sequence extending to  9.5kb
contains the mbp regulatory sequence so far characterized
for function using reporter genes and it confers cell speci-
ﬁcity and quantitative programming similar to that
realized by the endogenous mbp locus (29,31). Each
conserved mbp module (M1, M2, M3 and M4) has been
extensively analyzed by controlled transgenesis in order to
characterize its function and composite elements (27–30).
Consequently, the targeting and quantitative expression
programs conferred by 9.5kb of mbp 50-ﬂanking
sequence and each of the modules studied independently,
served as internal references for comparison of the
constructs analyzed in this investigation.
M3 enhances, but is not required for, mbp expression in
oligodendrocytes
The most proximal module, M1, contains the mbp
promoter and is capable of targeting expression to
oligodendrocytes, but not Schwann cells (29,30).
However, earlier observations, using both random and
controlled transgenesis, suggested that activity from M1
alone was transient and that sustained expression in the
oligodendrocytes of mature mice required M3 (29,39).
Subsequent investigations using controlled transgenesis
demonstrated that constructs lacking M3 were capable
of continued expression in mature mice, but only when
inserted in one orientation relative to HPRT (30). Here
we show that the 9.5-kb 50-sequence deleted of M3
(9.5M3) expresses in oligodendrocytes of both young
and mature mice, but at a level only 45% (P90) of that
realized from the intact 9.5-kb construct (Figure 2).
M1M3 drives maximal expression in adult
oligodendrocytes while maximal expression during myelin
biogenesis requires additional input from M2 and/or M4
M1M3 conferred post weaning expression to oligodendro-
cytes at levels similar to that realized by the 9.5-kb 50
ﬂanking sequence; a result indicating that M1 with M3
is sufﬁcient for maximal expression at P21 and P90
(Figure 2). Interestingly, at P21, a comparison of M1M3
to M1M2M3 or M1M2M3M4 demonstrates that M1 and
-9.5ΔM3
M4-M3-M2-M1
M4-M3-M1
M3-M2-M1
M4-M1
M3-M1
-9.5ΔM4
-9.5ΔI
M2-M1
-9.5 Kb mbp
M2 M3 M4 M1
Figure 1. Constructs docked as single copy at the hprt locus in trans-
genic mice. The constructs generated in this study contain different
deletions and combinations of mbp regulatory sequences, ligated to a
lacZ reporter gene. Mbp regulatory modules (M1–M4) are represented
as colored boxes whereas non-conserved inter-modular sequences are
shown in white. The ﬁrst construct contains 9.5kb of mbp 50-ﬂanking
sequence while the others bear deletions of modules and/or
intermodular sequences.
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express to higher levels than constructs containing the
additional modules (Figure 2, P21). Similarly, deletion of
M4 from 9.5kb (9.5M4) increased levels of expression in
oligodendrocytes by 39% at P21 and 82% at P90 (Cervical
spinal cord Figure 2). These data show that additional
module sequences interfere with maximal oligodendrocyte
expression thus revealing negative functional interactions
active in post weaning samples. In contrast, at P14, the
M1M2M3M4 and the intact 9.5-kb constructs expressed
in oligodendrocytes to levels higher than all other
constructs tested, demonstrating that M2 and/or M4 con-
tribute positively to oligodendrocyte expression at this
early age (Figure 2: 9.5kb, M1M3, M1M2M3,
M1M3M4, P14). Consistent with the positive activity
realized in P14 samples, constructs lacking M4 expressed
in oligodendrocytes at levels signiﬁcantly lower than that
realized by the 9.5-kb construct. Thus, M4, ﬁrst
recognized as an enhancer with targeting activity limited
to Schwann cells, also modulates expression in
oligodendrocytes in a developmentally contextual manner.
The proximal promoter plays a silencing role in
Schwann cells
The ﬁrst 6kb of mouse mbp 50-ﬂanking sequence includes
M1, M2 and M3, and demonstrates no activity in
Schwann cells (31). Consequently, it was unanticipated
that a reporter in which M3 alone was ligated to a
300bp hsp minimal promoter would acquire the ability
to drive expression in Schwann cells during myelin elab-
oration (29). As the minimal promoter itself does not
target Schwann cells, this observation requires that
cryptic M3 Schwann cell targeting activity normally is
suppressed through interactions with another 50-ﬂanking
sequence. To probe the potential role of promoter-
enhancer interactions in conferring this suppression, we
compared the expression programs realized from the
M1M3 and hspM3 constructs (Figure 3) and show that
the cryptic Schwann cell targeting activity is silenced
entirely when M3 is associated with M1, the 377-bp mbp
proximal promoter.
M4 alone drives high levels of expression in adult
Schwann cells but its activity is enhanced by M3
during myelin biogenesis
Deleting M4 from 9.5kb of 50-ﬂanking sequence (9.5M4,
Figure 4) silences reporter gene expression in Schwann
cells at all ages. Similarly, constructs regulated by
M1M2 and M1M3 fail to express above background
levels in Schwann cells, at all ages. These observations
are consistent with the autonomous and robust enhancer
activity that M4 exerts in Schwann cells, demonstrated
previously in the context of both randomly inserted trans-
genes and hsp promoted lacZ reporter genes inserted at
HPRT (27,29,31).
To explore the potential effects of other modules on M4
mediated Schwann cell expression, the quantitative
expression programs realized by all M4 bearing constructs
were compared. At P21 and P90, the M1M4 construct
expressed in Schwann cells in the same range as the
9.5-kb regulated construct (Figure 4) indicating that, at
these ages, M4 confers Schwann cell expression without
modulation arising through interactions with other
9.5
9.5ΔM4
9.5ΔM3
9.5ΔI
M1M2M3M4
M1M3M4
M1M2M3
M1M4
M1M3
M1M2
P21
P90
Cervical spinal cord
P14
# #
#
*
*
*
*
* #
*
*
#
0
100
200
300
100
200
300
100
200
300
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500
Figure 2. Expression phenotypes of mbp reporter constructs in oligo-
dendrocytes. The function of mbp regulatory sequences in oligodendro-
cytes was analyzed by measuring the b-galactosidase activity at
post-natal Days 14, 21 and 90 in cervical spinal cords. Signiﬁcant dif-
ferences (when P<0.01) are represented by asterisk or hash compared
to 9.5kb or M1M2M3M4, respectively. Comparisons between all con-
structs are shown in Supplementary Table S1.
M3-hsp M3-M1
Figure 3. M1 restricts expression of M3 to oligodendrocytes. Whole
mount histochemical preparations of mouse spinal cords at post-natal
Day 9 show that M3 ligated to the hsp minimal promoter drives lacZ
expression in both spinal cord (oligodendrocytes) and spinal roots
(Schwann cells). In contrast, expression is limited to oligodendrocytes
when M3 is ligated to the mbp M1 promoter.
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accumulation nears peak levels, constructs containing M3
(M1M2M3M4 and M1M3M4) expressed at levels signiﬁ-
cantly higher than M1M4 alone (Figure 4). Similarly, the
9.5-kb construct expressed at higher levels than 9.5M3
(460 versus 381, respectively P<0.02).
M2: a role in oligodendrocytes during myelin biogenesis
We showed previously that M1, the 377bp 50 of the trans-
lation start site, is sufﬁcient to drive expression in oligo-
dendrocytes and that by extending the sequence to
 794bp, to include M2, expression levels increased in
oligodendrocytes (29). However, when M2 was ligated to
an hsp minimal promoter in a lacZ-reporter construct, it
lacked autonomous targeting activity (28). To expose
further modulating activities, M2 was deleted from
M1M2M3M4. Consistent with our earlier observations,
M1M3M4 drove expression in the P14 cervical spinal
cord at only 64% of that realized by the parent construct
(Figure 2: 222±22 versus 348±55, respectively). Thus,
during myelin biogenesis, M2 contributes signiﬁcantly to
oligodendrocyte expression even in the presence of M3
and M4. However, at later ages, the M1M3M4 and the
M1M2M3M4 constructs expressed at similar levels (P21:
136±32 and 148±20; P90: 90±8.3 and 75±14, re-
spectively) demonstrating that M2 activity is maximal
during, and perhaps limited to, the period of CNS
myelin biogenesis (Figure 2). In the PNS, the M1M3M4
and M1M2M3M4 constructs expressed to similar levels at
all ages examined suggesting that M2 plays no signiﬁcant
role in Schwann cells (Figure 4).
Inter-module sequence
Deletion of all inter-modular sequences present in the
9.5-kb construct yielding the M1M2M3M4 construct
had no effect on the expression program realized in
maturing oligodendrocytes (Figure 2). As predicted by
this observation, removal of only the inter-modular
sequence lying between M2 and M3 (9.5I) also had no
affect on the oligodendrocyte expression program
(Figure 2). In contrast, deletion of inter-enhancer
sequences had signiﬁcant consequences on the expression
program realized in Schwann cells. Deletion of the
sequence lying between M2 and M3 reduced expression
at P21 to 68% of the 9.5-kb value (9.5I, 320±69
versus 9.5 475±73) while deletion of all other
inter-modular sequences had little additional effect
reducing expression to 61% of the 9.5-kb value
(M1M2M3M4 289.8±91 versus 9.5-kb 475±73)
(Figure 4). In contrast, at P90, the expression levels
realized by both deletion constructs revealed no signiﬁcant
differences (Figure 4). Similarly, at P14, the M1M2M3M4
construct expressed in the same range as the 9.5-kb
construct (479±81 versus 460±69, respectively).
Notably, at this young age, the construct deleted of the
non-conserved sequence between M2 and M3
demonstrated expression levels markedly higher than the
intact 9.5-kb construct (9.5: 460±69 versus 9.5I:
764±102).
M3 function in the endogenous golli-mbp gene
To evaluate potential regulatory interactions with
sequences extending beyond the 9.5kb of 50-ﬂanking
sequence evaluated in reporter genes, and to determine
the extent to which regulatory activity revealed by
reporter constructs docked at the HPRT locus re-
ﬂects function within the context of the endogenous
mbp locus, we derived mice bearing a mbp allele deleted
of M3 (Figure 5). M3 is located within the 50-ﬂanking
sequence of mbp and within intron 3 of the
overlapping golli transcriptional unit. Mice homozygous
for the M3 knockout allele (M3KO) demonstrated no
obvious behavioral abnormalities, and had normal
growth and reproductive performance (up to 1year of
age examined).
To evaluate the potential effects of M3 deletion on
transcription initiated by the mbp promoter in
oligodendrocytes, cervical spinal cord samples from
homozygous M3KO and wild-type litter-mates were
analyzed for relative levels of accumulated mbp mRNA
by real-time PCR. At all ages examined mbp mRNA
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Figure 4. Expression phenotypes of mbp reporter constructs in
Schwann cells. Graphs show levels of b-galactosidase activity realized
from mbp regulated reporter constructs in the sciatic nerves of trans-
genic mice at P14, P21 and P90. Signiﬁcant differences (when P<0.01)
are represented by asterisk or hash compared to 9.5kb or
M1M2M3M4, respectively. Comparisons between all constructs are
shown in Supplementary Table S2.
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Although in the predicted direction, the effect of the M3
deletion on the endogenous locus was not as strong as that
revealed by the 9.5-kb reporter construct deleted of M3 (at
P14, 9.5M3=18.3% of 9.5kb; at P21, 43% of 9.5kb
and at P90, 45% of 9.5kb). Similarly, comparison
between other reporter constructs with and without M3
showed that the presence of M3 had a greater effect on
expression of reporter genes than on the endogenous locus
(see Figure 2: M1M2 versus M1M2M3; M1M4 versus
M1M3M4).
To examine the role of M3 in the Schwann cell lineage,
mbp mRNA accumulation in sciatic nerve samples from
homozygous M3KO mice at P14 was evaluated. No sig-
niﬁcant alteration in mbp mRNA accumulation was
detected (Figure 6).
As noted above, the mbp gene lies within the more
widely expressed golli transcriptional unit and we there-
fore investigated the potential effect of its deletion on golli
transcription. We ﬁrst compared golli mRNA accumula-
tion in the cervical spinal cord of homozygous M3KO
mice. At P12, P21 and P60, M3KO mice accumulated
only 10% of wt golli mRNA levels (Figure 7). Golli
transcripts accumulate in a developmental program
distinct from mbp extending to multiple neuronal popula-
tions in addition to oligodendrocytes (42,43). Thus, to
evaluate the possibility that golli expression was complete-
ly silenced in spinal cord oligodendrocytes, while still ex-
pressed in neurons, we next examined optic nerves that are
richly invested with oligodendrocytes but contain no
neuronal cell bodies. Optic nerves of M3KO mice
accumulated golli mRNA at levels similar to that
observed in the spinal cord (15% of wt, Figure 7)
leading to the conclusion that golli expression in oligo-
dendrocytes is massively down regulated, but not
entirely silenced, when M3 is absent; an observation sug-
gesting that M3 engages both of the widely separated
(>79kb in mouse) mbp and golli promoters.
DISCUSSION
The regulatory roles played by speciﬁc enhancers and the
promoter of the mbp gene were shown here to be
modulated through partnerships elaborated among
them. Such modulation was either positive or negative
and extended to both qualitative and quantitative
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2554 Nucleic Acids Research, 2011,Vol.39, No. 7expression phenotypes. Furthermore, modulation was
contextual on both the glial lineage and stage of matur-
ation. Myelin elaboration takes place over a short time
span during which glial cells support intense membrane
and myelin protein synthesis. Upregulated expression of
numerous genes accompanies this process and at P14,
active myelination is ongoing and near peak levels of
myelin gene expression are realized in both spinal cord
oligodendrocytes and sciatic nerve Schwann cells.
During the period when myelin elaboration is most
active, the interactions we encountered typically led to
upregulated reporter expression. Also at that stage, enhan-
cers demonstrating autonomous targeting activity in only
one glial lineage were nonetheless capable of contributing
to reporter expression in the other. In contrast, by P21
when most myelin has been elaborated and many myelin
genes, including mbp, are downregulated, regulatory inter-
actions tended to be less dramatic or resulted in negative
effects. Consistent with this overall program, the reporter
regulated by M3hsp expressed in Schwann cells only
during the period of most intense myelin elaboration.
Notably, interaction between M3 and the proximal
promoter silences even this transient activity in Schwann
cells. In the related M3 knockout experiment, we show
that M3 up-regulates expression of the endogenous mbp
locus in oligodendrocytes. Although that role was
predicted by its oligodendrocyte targeting capacity, unex-
pectedly it also functions as the major enhancer of the golli
promoter in oligodendrocytes. Finally, non-conserved
inter-enhancer sequence was shown to affect regulatory
activity, although only in myelin elaborating Schwann
cells. These combined observations demonstrate that an
additive model of enhancer activity cannot account for
the integrated activity of mbp/golli regulatory sequences
and highlights a seemingly ubiquitous role for regulatory
sequence interactions in the mechanism controlling
transcription.
Physical association of regulatory modules
The mechanism through which regulatory sequence inter-
action modulates gene expression is unknown. However,
3C and 4C studies with other loci strongly support looping
models in which enhancer function is conferred through
close physical association with the proximal promoter
(24). Beyond the demonstrated association of promoters
and enhancers, evidence has emerged for the existence of
transcription factories where co-localization occurs
(25,44,45). In this model, PolII and its related factors
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extension of this model proposes that specialized factories
enriched in a particular combination of transcription
factors may self-organize by the preferential
co-localization of co-regulated genes sharing those tran-
scription factors (46). Consistent with this, erythroid
Klf1-dependent co-regulated genes appear to preferential-
ly associate (47). Other active erythroid genes that were
not dependent on Klf1 did not show similar
co-localization supporting the notion that the speciﬁcity
of these factories is based on shared regulatory factors.
They also observed that randomly inserted YAC trans-
genes carrying the Hbb locus co-localized with the en-
dogenous Hbb locus indicating that an active transgene
locus can bring its ectopic chromosomal site to the
relevant specialized factory. In like manner, the rapid
and co-ordinate up-regulation of the myelin gene family
during myelin biogenesis could be greatly facilitated in an
environment rich in speciﬁc factors. Co-localization of
oligodendrocyte and Schwann cell enhancers (e.g. M3
and M4) could be one factor contributing to their ability
to modulate each other’s activity. Thus, it will be import-
ant to determine the extent to which the functionally inter-
acting golli/mbp sequences, along with the known
regulatory sequences of other co-regulated myelin genes,
co-localize during the maturation of myelin forming
cells (23).
If the interactions at specialized transcription factories
followed a stoichiometric model, deletion of M3 could
affect the expression of other myelin genes. However, it
is thought unlikely that the deletion of one enhancer
would affect transcription of co-regulated genes at a
specialized factory formed in its absence (47). Consistent
with this notion, we observed no change in the
accumulated mRNA levels of the myelin genes plp and
mag in the cervical spinal cord of M3KO mice (data not
shown).
Intervening DNA
Looping models of enhancer function assign little or no
functional signiﬁcance to inter-modular DNA. However,
in a recent review, Bulger and Groudine (48) suggested
that enhancer-promoter co-localization might be estab-
lished through a process requiring the intervening DNA
sequences (49–51). In the present investigation, close
juxtaposition of all four mbp regulatory modules had no
signiﬁcant effect on either the qualitative or quantitative
expression programs realized by any reporter gene
expressed in oligodendrocytes at any age. By experimen-
tally bringing the modules into close proximity, it is
possible that loops and the related function associated
with the intervening DNA become unnecessary.
Alternatively, any requirement for inter-enhancer
sequence might be accommodated by the short, non-
conserved, enhancer ﬂanking sequences remaining within
such constructs.
In contrast to oligodendrocytes, deletion of
inter-enhancer sequences signiﬁcantly affected the expres-
sion programs realized in Schwann cells. Speciﬁcally, when
compared to the 9.5-kb construct, the expression levels
realizedinSchwanncellsbytheM1M2M3M4module-only
construct were reduced at P21 and P90 while at P14, the
9.5kb construct deleted only of inter-enhancer I (9.5I)
revealed an up-regulated expression program. Whether
this signiﬁes a lineage speciﬁc role for inter-enhancer se-
quences or the presence of currently unrecognized TFBS
in the deleted sequence remains unresolved.
Enhancer sharing: mbp and golli
Previously, 1.1kb of golli 50-ﬂanking sequence was shown
to drive golli expression in fetal neurons but not in the
oligodendrocyte lineage (52,53). We show here, in
addition to its well-characterized role in regulating tran-
scription of mbp, M3 enhances expression from the
upstream golli promoter where it accounts for 90% of
its output in oligodendrocytes. Several loci conﬁgured
with multiple promoters regulated by common enhancers
have been described previously (14,26,54–58). The mech-
anism through which an enhancer simultaneously affects
the activity of multiple promoters in the same cell is not
known but a dynamic physical interaction among the
three sequences appears likely. This could take the form
of a ‘ﬂip-ﬂop’ model, as proposed for the globin locus
where regulatory sequence switches back and forth
between two genes (59) or a hit-and-run (60) mechanism.
Alternatively, the enhancer may be able to form a complex
with both promoters concurrently, a circumstance poten-
tially facilitated in the context of a common transcription
factory (26).
In this investigation, functional interactions realized by
multiple mbp/golli regulatory sequences have been
revealed through the output of HPRT docked constructs
and an endogenous allele deleted of M3. Although M3
deletion in the endogenous locus led to downregulation
of mbp, the extent of the downregulation was not as
extensive as that predicted by HPRT docked constructs.
Thus, the large golli/mbp locus may contain additional
mbp regulatory sequence/s partially compensating for the
loss of the M3 enhancer. Alternatively, the different chro-
matin environments, inter-genic interactions involving the
regulatory sequences controlling HPRT expression, or
competition for different transcription factories might all
contribute to such quantitative differences.
Finally, the present understanding of transcriptional
regulation and regulatory sequence interactions has been
achieved through insights obtained with multiple highly
diverse experimental approaches (61). Here, using in vivo
functional analysis we demonstrate that functional inter-
actions between regulatory modules are commonplace ex-
tending to both qualitative and quantitative expression
phenotypes. Although the positive or negative conse-
quences of such interactions are currently unpredictable,
this investigation has assigned their origin to speciﬁc
sequence domains within the mbp 50-ﬂanking sequence
thus providing insight that should facilitate future
investigations.
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